{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"8.1","upperLimit":"15.3","value":"12.6"},{"groupId":"OG001","lowerLimit":"8.5","upperLimit":"24.5","value":"14.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"25"}],"units":"Participants"}],"description":"The Kaplan Meier methods will be used to estimate progression free survival.","dispersionType":"95% Confidence Interval","groups":[{"description":"Head and Neck Squamous Cell Carcinoma patients","id":"OG000","title":"Head and Neck Squamous Cell Carcinoma"},{"description":"Salivary Gland Carcinoma patients","id":"OG001","title":"Salivary Gland Carcinoma"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Up to 2 years","title":"Progression Free Survival","type":"SECONDARY","unitOfMeasure":"Months"}